Bremelanotide in women with hypoactive sexual desire disorder: pooled phase 3 analysis
study081
10.1016/j.jsxm.2020.07.004
Sexual Medicine
clinical trial analysis
Pooled analysis of phase 3 bremelanotide trials in premenopausal women with HSDD.
Bremelanotide improved desire and reduced distress compared with placebo.
pt-141
libido
libido-stack
pt141-vs-viagra
published